Navigation Links
MonoSol Rx Appoints Theodore Clemente Vice President Business Development
Date:7/23/2009

ment and managerial positions with Ciba Self-Medication, Inc., Hoechst-Roussell Pharmaceuticals and Bristol-Myers Products. Mr. Clemente is a graduate of Rutgers College of Pharmacy, Rutgers University.

About MonoSol Rx

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm(R) technology to deliver drugs in quick dissolving films. PharmFilm(R) is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in thin film drug delivery is supported by strong intellectual property, a portfolio of commercialized over-the-counter (OTC) drug products, and a development pipeline of prescription formulations based on PharmFilm(R) technology. With a vertically integrated development and production infrastructure, MonoSol Rx has the capacity to manufacture OTC drug products for near-term revenues that fund prescription product development programs that will generate long-term value.

The Company's commercialization strategy for all PharmFilm(R) products is to partner with the innovator, other specialty pharma or leading consumer products companies that can sell-in and manage product sales and marketing. For existing and future partners, PharmFilm(R) formulations represent revenue-life cycle extensions for products with patent lives that have expired or are approaching expiration. PharmFilm(R) is also a tool to help sales and marketing partners differentiate in competitive markets while offering unique advantages over drugs dosed by traditional tablets, capsules and orally disintegrating tablets (ODTs).

    The Ruth Group                        Contact:
    Jason Rando (media)                   MonoSol Rx
    (646) 536-7025                        Keith Kendall
    jrando@theruthgroup.com               Chief Financial Officer
'/>"/>
SOURCE MonoSol Rx
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip
2. MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip
3. MonoSol Rx Granted U.S. Article of Manufacture Patent
4. MonoSol Rx Enters Agreement with Hikma Pharmaceuticals PLC for Thin Film Pharmaceutical Products in the Middle East
5. MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA
6. MonoSol Rx to Present at the 20th Annual Piper Jaffray Health Care Conference
7. Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
8. MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
9. MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations
10. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
11. WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... procedures and executing them with care and precision. There is an art and ... has had the honor of successfully reshaping the facial features and lives of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at the University ... through five federal grants to study a group of related mosquito-borne viruses. The ... , The research will be conducted in the Regional Biocontainment Laboratory (RBL) at ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, ... retained to lead a national chief executive officer recruitment for Indiana ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the Gelatin Capsule manufacturers. The report is a valuable source of guidance ... depicts the global and Chinese market for the Gelatin Capsule industry including capacity, ...
(Date:7/2/2015)... Mobile, AL (PRWEB) , ... July 02, 2015 , ... Every year, DUI arrests and ... of July may be the deadliest day of the year when it comes to being ... , “The National Highway Traffic Safety Association reports that 40% of all highway deaths between ...
Breaking Medicine News(10 mins):Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Attorney David Maloney Stresses Safety through Sobriety 2
... with depression, bipolar disorders could receive more targeted treatment ... types of imaging techniques enable researchers to map brain ... in depression, bipolar disorder and other mood disorders, and ... these techniques was expected to be presented Tuesday during ...
... to Secondhand Smoke,in the Nation,s Capitol, Statement of ... 6 On behalf of the American,Lung Association, I ... (D-OH), Dick Durbin (D-IL) and Jack Reed (D-RI) for,their ... in the,Senate. For too long, Senators, staff and visitors ...
... XM Satellite Radio announced today,the second annual ... Sam,s Club raise $10 million in May for ... and improving the,lives of children at hospitals across ... The XMKiDS Traveling Roadshow will kick-off on ...
... France, May 6 NicOx S.A.,(Euronext Paris: COX) ... 2 study,conducted by its partner Pfizer Inc, which ... PF-03187207 to Xalatan(R) (latanoprost) 0.005% in,patients with primary ... PF-03187207 demonstrated a clinically significant reduction,in diurnal intraocular ...
... into melanoma by showing the interaction of two key ... Penn State scientists also demonstrate that therapeutic targeting of ... this deadly form of cancer. , "We have shown ... communicate with one another in a mole, they cooperate ...
... Health Inc. (TSX: DAX),(Nasdaq: DRAX ) will report ... Friday May 9, 2008., Annual and Special Meeting ... "Meeting") of shareholders of,DRAXIS is scheduled to be held ... Bank Tower, Toronto, Ontario, Canada on Friday, May 23, ...
Cached Medicine News:Health News:Imaging Advances Map Brain Areas Affecting Mood 2Health News:Imaging Advances Map Brain Areas Affecting Mood 3Health News:American Lung Association Hails Decision to Snuff Out Smoking in U.S. Senate Lounges 2Health News:XM Launches Second Annual 'XMKiDS Traveling Roadshow' National Initiative Benefiting Children's Miracle Network 2Health News:XM Launches Second Annual 'XMKiDS Traveling Roadshow' National Initiative Benefiting Children's Miracle Network 3Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 2Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 3Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 4Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 5Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 6Health News:Scientists identify interacting proteins key to melanoma development, treatment 2Health News:Scientists identify interacting proteins key to melanoma development, treatment 3Health News:DRAXIS to Report First Quarter Results on May 9th 2Health News:DRAXIS to Report First Quarter Results on May 9th 3Health News:DRAXIS to Report First Quarter Results on May 9th 4
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
(Date:7/2/2015)... South Korea, July 2, 2015 ALPINION MEDICAL SYSTEMS ... E-CUBE Series ultrasound system. Developed to enhance user experience ... the E-CUBE 15 EX produces superb image quality. With ... in women,s health, general imaging, and shared service applications. ... latest in the renowned E-CUBE Series, the E-CUBE 15 ...
(Date:7/2/2015)... July 2, 2015   Wilson Therapeutics AB , ... Hans Schikan to its board of directors. The appointment ... Meeting on June 30. "We are delighted ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans ... we look forward to his contributions to the Company." ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... WALTHAM, Mass., Sept. 23 Interleukin Genetics, ... top-line positive results from a retrospective clinical study on ... study previously reported in the Journal of the American ... following diets matched to their genotype, as determined by ...
... , , NOVATO, Calif., Sept. ... today that the first patient has initiated treatment in the Phase ... the treatment of phenylketonuria (PKU). Initial top-line results are expected in ... program and believe that, if approved, PEG-PAL may offer a significant ...
Cached Medicine Technology:Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss 2Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss 3BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU 2BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU 3
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
... Tip flattened and angled 90 1.0mm from end, ... lock high pressure extension tubing set, Capable of ... OD- 1.5mm (.06 in) long luer lock, high ... tubing. Bend 1.0mm from end. (Cannulas ...
Rounded tip for even incisions reducing post-op astigmatism...
Stab incision blades color coded for simple and accurate identification...
Medicine Products: